socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•

    Search News
    Wednesday, March 23, 2005

    Kalypsys Appoints CEO
    San Diego-based Kalypsys, a drug discovery company focused on developing new medicines for cancer, inflammation, and metabolic diseases, has named a new CEO. Dr. John McKearn, the company's Chief Scientific Officer, has been promoted to CEO. McKearn was previously at Pharmacia, as well as G.D. Searle.
    posted on Wednesday, March 23, 2005

    Related companies:
    Kalypsys

    Related stories:
    > Kalypsys Completes $29M Series B
    > Kalypsys Raises $100M
    > Eidogen-Sertanty Signs Deal with AstraZeneca
    > Asteres Appoints CEO
    > eCost Appoints CEO

    RSS subscri be via emailEmail Twitter


    Previous news:

     Thursday, December 4, 2008
    Wednesday, December 3, 2008
    Tuesday, December 2, 2008
    Monday, December 1, 2008
    Wednesday, November 26, 2008